RLS Global: Platform Potential

Initiating Coverage

2020-04-17

07:20

Redeye initiates coverage of RLS Global, a Swedish medtech company that develops unique, high quality wound care products. We believe that the recent actions taken to become a pure wound care company are strategically right and believe that there is a hidden potential in the company’s proprietary buffered hypochlorite platform, from which its wound debridement product ChloraSolv has been developed.

EN

OB

Erik Nordström

Oscar Bergman

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.